Mind Cure Announces New Product, Launch Dates For Nootropic Products

Mind Cure Health (CSE: MCUR) this morning announced that it intends to bring a new product to market in early 2021. Referred to as Mind Cure Teen, the product is an all natural supplement that has been designed to “relieve restlessness and nervousness in teens.”

More specifically, the product has been designed to relieve restlessness, nervousness, and sleeplessness that is caused by mental stress. The company doesn’t address specifically how it relieves mental stress, instead stating that it includes all-natural ingredients that includes botanicals, vitamins, and minerals.

In terms of product launch, the product will become available for pre-order on the firms website next week, with delivery slated to begin in February. Separately, the company also announced this morning that three other nootropic products, referred to as Mind Cure Lion’s Mane Focus, Mind Cure Turkey Tail Immunity, and Mind Cure Reishi Energy, will become available in both powder and capsule form in February as well. Those products are slated for a pre-order launch in late January.

“Mind Cure Teen supplement is our first step in supporting young people. Down the road, our digital therapeutics will provide a way for teens to be further supported in the optimization of their own mental wellness to pursue their aspirations.”

Kelsey Ramsden, Mind Cure President and CEO

Mind Cure Health last traded at $0.70 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

First Majestic Q1 Earnings: A Bang Up Quarter

Copper’s Structural Shortage May Be Here to Stay | Colin Joudrie – Selkirk Copper

Why Barrick’s “Strong” Quarter Wasn’t So Strong | Q1 2026 Earnings

Recommended

Canada Confirms First Hantavirus Case Linked to MV Hondius Cruise Ship Outbreak

Altamira Gold Extends Maria Bonita Porphyry System Westward With 70.6 Metres At 0.51 g/t Hit

Related News

Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review

In a sign of what’s to come for most psychedelic-related names, Mind Cure Health (CSE:...

Wednesday, March 16, 2022, 11:58:00 AM

Mind Cure Doubles Bought Deal Financing To $20 Million

Strong demand continues within the psychedelics space, with Mind Cure Health (CSE: MCUR) announcing earlier...

Friday, January 22, 2021, 02:07:33 PM

Mind Cure Appoints Dr Wolfram Tetzlaff To Advisory Board

It appears that Mind Cure Health (CSE: MCUR) is not quite yet done compiling its...

Tuesday, October 13, 2020, 09:01:47 AM

Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health

In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably...

Sunday, November 1, 2020, 09:00:00 AM

Mind Cure Appoints Kelsey Ramsden As CEO And President

Mind Cure Health (CSE: MCUR) has shaken up its management team slightly, promoting COO Kelsey...

Tuesday, December 1, 2020, 08:51:06 AM